If you live with thumb pain or wrist arthritis, you know how it changes your daily life. Simple tasks like opening a jar or turning a key can hurt. You may feel frustrated when medicines and therapy do not help much.
Scientists are testing a new treatment that mixes your own fat and platelets from your blood. This study looked at how safe this treatment is and whether it helps people with severe wrist arthritis feel less pain.
Key Findings at a Glance
- The treatment uses your own body’s healing cells from fat and blood
- All three patients in this early study had less pain after one year
- The only side effect was soreness where doctors took the fat tissue
What is this new treatment?
Let us start with what doctors are trying. They created something called an Advanced Therapy Medicinal Product. That term is complicated, but it means a special medicine made from your own body.
Doctors take a small amount of your fat tissue. They break it down into very tiny pieces called microfat. Then they mix this microfat with platelet rich plasma from your own blood.
You may be wondering why fat matters. Fat tissue contains special cells called stromal vascular fraction cells. These cells can help your body repair damage and calm down inflammation.
How did researchers test it?
The scientists tested this treatment on three patients who had very severe wrist arthritis. These patients had already tried other treatments like medicines and therapy. Nothing had worked well enough.
Here is where it gets interesting. Before using the treatment on patients, researchers did many tests in the laboratory. They wanted to make sure the mixture was safe and contained the right healing cells.
Who could join this study?
Patients in this study had to meet specific criteria. They had stage four osteoarthritis according to a rating system doctors use. Stage four means the arthritis is very advanced.
They also had to have daily pain that measured more than 40 millimeters on a special pain scale. That pain scale goes from zero to 100, so 40 means moderate to severe pain.
Conservative treatment had already failed for these patients. Conservative treatment means non-surgical options like pills, splints, and exercises.
What tests did scientists do?
According to this study, researchers examined the biological characteristics of the treatment. They looked at the mixture under microscopes. They counted how many healing cells survived in the mixture. They tested whether the cells could turn into cartilage cells. Cartilage is the cushion material in your joints.
They also measured something called IL-1Ra. This is a natural substance your body makes that fights inflammation. The mixture had high levels of this helpful substance.
What did they find?
Research shows that the treatment had several positive features. The platelet rich plasma part had high purity. That means it contained mostly platelets and not many other blood cells you do not need.
The cells from the fat tissue stayed alive in the mixture. This matters because living cells do the healing work. Dead cells cannot help.
Did it help with pain?
Let us look closer at the results for patients. All three patients had much less pain one year after the injection. Studies indicate that their pain decreased by over 50 percent according to the visual analog scale.
| Measurement | Result After One Year |
|---|---|
| Pain Reduction | Over 50% decrease on pain scale |
| DASH Score | Reached minimal important improvement |
| PRWE Score | Reached minimal important improvement |
The DASH and PRWE scores are questionnaires that ask about how your hand works in daily life. Can you write? Can you hold things? Can you dress yourself? All three patients improved enough on these scores to reach what doctors call minimal clinically important differences. That means the improvement was big enough to actually matter in daily life.
Were there side effects?
Medical evidence from this study suggests that the treatment was safe. The only side effect patients experienced was pain at the place where doctors took the fat tissue. This pain was temporary. No other problems happened.
This is important because any new treatment must first prove it does not harm people. Only then can doctors study whether it truly helps.
What does this mean for you?
This study was very small. Only three patients received the treatment. Scientists needed to start small to check safety first. You may be wondering if this treatment could work for you.
The honest answer is that we need more research. Larger studies with more patients are necessary. Doctors need to compare this treatment to other treatments or to no treatment. Only then can they know for sure how well it works.
However, the results are encouraging. According to research published in the International Journal of Molecular Sciences, this innovative strategy could potentially delay the need for surgery in people with severe wrist arthritis.
Could this work for thumb arthritis?
This study looked at wrist arthritis. The researchers did not test it on thumb arthritis, which doctors call rhizarthrosis (thumb arthritis). But the idea could apply. Both conditions have worn cartilage and inflammation in the joints.
Future studies may check if the same treatment helps thumb joints. For now, we can only say it showed promise in wrist joints.
About This Site: We help people understand medical research about thumb pain and rhizarthrosis. Every article on this site comes from real published scientific studies. We read the complicated medical papers and explain them in plain language. You can trust that everything here is based on actual research, not opinions or advertising. Feel free to explore more articles to learn about your condition and the latest treatment options.
Common Questions
Is this treatment available now?
This treatment is still experimental. The study described here was an early safety test. It is not yet available as a standard treatment. More research trials are happening now to see if it truly works.
Does the injection hurt?
The study did not report pain from the injection itself. The only pain mentioned was at the spot where doctors removed fat tissue. That pain was temporary and manageable.
How long does the treatment take?
The study does not say exactly how long the procedure takes. It involves collecting fat tissue and blood, preparing the mixture, and then injecting it into your wrist joint. This likely takes a few hours total.
Will insurance cover this treatment?
Because this is experimental, insurance likely does not cover it yet. If larger studies prove it works well, insurance companies may cover it in the future.
What should I do next?
If you have severe wrist or thumb arthritis that has not improved with regular treatments, talk to your doctor. Ask if any clinical trials are testing new treatments like this one. Your doctor can help you understand all your options.
Remember that this study showed promise but was very small. Bigger studies are needed. Stay hopeful but also patient as science moves forward.
Keep doing the treatments that do help you now. Exercises, splints, and pain medicines still have their place. New treatments like this one may add to your options in the future.
You are not alone in dealing with joint pain. Researchers around the world are working to find better ways to help you feel better and keep using your hands.
Important information
This article explains scientific research. It is not medical advice. Do not make treatment decisions based only on what you read here. Always talk to your doctor about your specific situation. Your doctor knows your medical history and can give you personal advice. Every person is different, and what works for one person may not work for another.
Scientific Source
Study Citation: Mayoly, A., Iniesta, A., Curvale, C., Kachouh, N., Jaloux, C., Eraud, J., Vogtensperger, M., Veran, J., Grimaud, F., Jouve, E., Casanova, D., Sabatier, F., Legré, R., & Magalon, J. (2019). Development of Autologous Platelet-Rich Plasma Mixed-Microfat as an Advanced Therapy Medicinal Product for Intra-Articular Injection of Radio-Carpal Osteoarthritis: From Validation Data to Preliminary Clinical Results. International Journal of Molecular Sciences, 20(5), 1111.